- Home
- RDHL vs MOVE Comparison
RDHL vs MOVE Comparison
Compare RDHL & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- MOVE
- Stock Information
- Founded
- RDHL 2009
- MOVE 2018
- Country
- RDHL Israel
- MOVE United States
- Employees
- RDHL N/A
- MOVE N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RDHL Health Care
- MOVE Health Care
- Exchange
- RDHL Nasdaq
- MOVE Nasdaq
- Market Cap
- RDHL 3.9M
- MOVE 4.5M
- IPO Year
- RDHL N/A
- MOVE 2021
- Fundamental
- Price
- RDHL $1.02
- MOVE $11.31
- Analyst Decision
- RDHL
- MOVE
- Analyst Count
- RDHL 0
- MOVE 0
- Target Price
- RDHL N/A
- MOVE N/A
- AVG Volume (30 Days)
- RDHL 1.6M
- MOVE 2.5M
- Earning Date
- RDHL 09-05-2025
- MOVE 11-14-2025
- Dividend Yield
- RDHL N/A
- MOVE N/A
- EPS Growth
- RDHL N/A
- MOVE N/A
- EPS
- RDHL N/A
- MOVE N/A
- Revenue
- RDHL $9,550,000.00
- MOVE $500,000.00
- Revenue This Year
- RDHL $381.91
- MOVE $1,460.71
- Revenue Next Year
- RDHL N/A
- MOVE $96.77
- P/E Ratio
- RDHL N/A
- MOVE N/A
- Revenue Growth
- RDHL 157.62
- MOVE N/A
- 52 Week Low
- RDHL $1.02
- MOVE $4.67
- 52 Week High
- RDHL $8.75
- MOVE $69.68
- Technical
- Relative Strength Index (RSI)
- RDHL 31.69
- MOVE 66.26
- Support Level
- RDHL $1.02
- MOVE $9.49
- Resistance Level
- RDHL $1.11
- MOVE $16.77
- Average True Range (ATR)
- RDHL 0.14
- MOVE 2.06
- MACD
- RDHL -0.01
- MOVE 0.25
- Stochastic Oscillator
- RDHL 3.45
- MOVE 40.19
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About MOVE Movano Inc.
Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.